Eat Smart is an RCT, which will be reported to be compliant with the CONSORT guidelines [31]. This study design has been approved by the Royal Children's Hospital & Health Service District Ethics Committee (05/02/2008); The University of Queensland Medical Research Review Committee (14/02/2008); West Moreton South Burnett Health Service District Health Research Ethics Committee (25/08/2008) and The Mater Health Services Human Research Ethics Committee (02/02/2009).
Figure 1 shows the study flow. Tables 1 and 2 show an outline of the content of the preparatory phase; 'the 'FRIENDS' program (Table 1) and the intervention phase (Table 2).
Table 2 Content Covered in Sessions delivered one to one with therapist
Overall Eat Smart provides a treatment protocol for use at a tertiary centre to assist obese adolescents seeking weight loss advice to reduce their weight. The first phase will evaluate the relative efficacy of two supported and structured 12 week weight reduction diets and an untreated control group:
-
(i)
reduced carbohydrate (35% carbohydrate, 30% protein, 35% fat)
-
(ii)
reduced fat (55% carbohydrate, 20% protein, 25% fat)
-
(iii)
control - offered the dietary group of their choice (i or ii) after a 12 week waiting period
The primary outcome variable is reduction of BMI z-score. Secondary outcome variables are reduction in body fat and alteration in metabolic profile after 12 weeks. The psychological diagnostic interviews will document the extent and nature of psychological health in obese adolescents. In the second phase, with follow-up to 24 weeks, the relative efficacy of the low fat versus the reduced carbohydrate diet on BMI z-score.
Hypotheses to be tested
After 12 weeks
-
There will be a difference in change in BMI z-score between the intervention diets and the control group.
-
There will be a difference in the change of mean BMI z-score between the low fat and the reduced carbohydrate group.
-
There will be a difference in the change of % body fat, markers of inflammation, insulin resistance and in lipid profile between the reduced carbohydrate group and the low fat group.
After 24 weeks
Recruitment
All volunteers will be screened via telephone to ensure they meet the inclusion criteria. Participants meeting these criteria will be examined by the study physician (JAB) who will confirm their eligibility, complete a standardised physical examination which includes pubertal staging and measurement of blood pressure.
Selection Criteria
Inclusion
Participants are sought who are aged between 10-17 years; have BMI >90th percentile, as defined by CDC 200 growth charts; can read and understand written instructions in English; and have parents able to give informed written consent.
Stage 1 Exclusion
Young people will be excluded on the basis of taking stimulants or psychotropic medication or drugs known to alter body composition or metabolism including insulin sensitisers, glucocorticoids and thyroxin, those with obesity associated with a medical condition such as Down's Syndrome and those following severely restricted diets, such as those for complex food allergies.
Stage 2 Exclusion
Participants will undertake the Anxiety Disorder Interview Schedule (ADIS) conducted by a Clinical Psychologist after completion of the psychological skills programme [27] prior to randomisation (Measurement1) and at Measurement 2 to investigate any alteration in psychological functioning post intervention (see figure 1).
In the event that the psychological ADIS interview suggests the presence of significant and clinically relevant levels of anxiety, depression, dysthymia, conduct disorders, eating disorders, psychotic disorders, attention deficit disorders and obsessive compulsive disorders, young people will be excluded and referred for clinical psychological services in conjunction with their referring doctor. This will be facilitated via the study and psychological sessions will be arranged through a Mental Health Care Plan, therefore with no out of pocket costs to the family.
This will ensure all volunteers must score below the cut offs for clinical diagnosis on the following validated questionnaires: The Strengths and Difficulties questionnaire[32]; the Depression, Anxiety and Stress Scale [33]; the Spence Children's Anxiety scale [34]; and the Children's Depression Inventory [35].
Ethical considerations
Lack of treatment for the obese child should not be an option as weight gain in those not treated is unrelenting. A recent meta-analysis of randomised controlled trials for treatment of overweight in children clearly demonstrates that control groups whether wait listed or only given written information consistently gained weight (2.1% increase in % overweight post treatment and 2.7% post follow-up) [36]. This increase in weight in control groups raises ethical issues around having a control group, especially in a clinical setting with children presenting for assistance with weight loss. We received ethical permission to delay treatment in a control group for 12 weeks after which we offer the program of their choice. These ethical issues will limit the ability to design trials with a control group remaining without intervention for lengthy study duration, especially in treatment seeking adolescents.
Interventions
A 12-week dietary intervention will be delivered by paediatric dietitians with training in behaviour modification. To ensure intervention fidelity across the two treatment arms, a standardised manual including protocols, procedures and participant materials will be used. All intervention families will be offered face to face tailored advice in the active weight loss phase in weeks 0, 2, 6, 10 and 12. Further dietary counselling will be provided by telephone in weeks 1, 4, 8 and 11. These follow a pre-determined outline to ensure consistency across treatment arms. The dietetic intervention is deliberately intensive in keeping with recent recommendations for best practice dietary management of obesity [37]. It is recognised that dietary advice must be delivered using a client-centred approach and motivational interviewing in tandem with behavioural components including problem-solving, goal-setting and self-monitoring [37, 38]. We will use two strategies to achieve these goals. First, the use of experienced paediatric dietitians to deliver the dietary advice and secondly, by preparing the adolescents and equipping them with the skills they need via the FRIENDS programme prior to the RCT commencing. The diets are to be used within the family context. We are cognisant of the fact that many parents are overweight (>90% in our feasibility study) and thus will adopt a 'treat the family' approach. Written information (diet sheets, meal plans, recipe ideas and shopping lists) which supports each of the diets have been developed. An outline of each session is summarised in Table 2.
Energy prescription
A tailored individual energy prescription for the intervention diets will be based on a 20% energy reduction compared to estimated energy requirements, which will be measured resting energy expenditure and physical activity level (PAL) derived from a 4 day activity diary. The 12 week intervention is designed to be an active weight loss phase. During the 'Maintenance Phase' (weeks 13-24), the goal is weight stability and maintenance of healthy behaviours.
Intervention diets
Both dietary plans use a structured approach with a plate portion system to assist with portion sizes for the evening meal. The dietary approaches utilised in the intervention have been tested within the feasibility stage of this project. The plate templates (TEMPlate™) have necessarily different size sections for the low fat and the reduced carbohydrate diets to enable the desired macronutrient composition of the meal to be achieved. In addition, a lunch box is provided with lists of foods for snacks and lunch that can be swapped by the individual. This enables food items for the day to be packed and given to the child or kept in the fridge if the parent is not around at meal or snack times. We have found that the benefits of using this structured system are that both the parent and child know what foods are allocated through the day for most meals, the plate template assists with portion control at the evening meal and the 'food swapping' system allows flexibility with food choices over a long period of time, whilst controlling the macronutrient distribution of the diet. The plate template is made of durable plastic and is dishwasher proof.
Reduced carbohydrate
A reduced carbohydrate (35% of energy) diet with moderate-high protein intake (30% of energy) and fat (35% of energy) with unsaturated sources of fat strongly encouraged. This level of carbohydrate restriction is not sufficient to induce ketosis [39]. Complex carbohydrates are spread over the day and given in a structured amount at each meal or snack with an emphasis on those with a low glycaemic index. Protein is increased with the intent to give greater satiety.
Low fat
A low fat diet containing (25% of energy from fat) with a higher carbohydrate intake (55% of energy) with complex carbohydrate sources encouraged and a moderate protein intake (20% of energy). This dietary approach recommends low fat foods and snacks and increases fruit and vegetable intake.
Control group
The control group will be offered treatment for 24 weeks after the formal control period (of 12 weeks).
Physical activity and sedentary behaviours
The intervention groups will receive the Australian National Health and Medical Research Councils 'Get out and get active' booklet. Emphasis will be placed on a reduction in sedentary behaviours. Activity will be measured by qualitative comparison of the measures from The Adolescent Physical Activity Recall Questionnaire [40] and a 4 day physical activity diary which will be completed at M1 and M2 (all groups).
Assessments and Measurement instruments
The laboratory technician conducting body composition measurements will be blinded to group allocation. The following assessments will be completed at M1 and M2 unless otherwise stated (see figure 1).
Anthropometry and body composition
These measurements will be undertaken by the body composition laboratory technician using standard operating procedures. Height, weight, waist and hip circumferences will be measured. BMI z-score will be calculated by the LMS method [41] using CDC reference data. Body composition will be assessed by 3 methods: air displacement plethysmography (BodPod™), total body potassium (TBK) and bioelectrical impedance (Bodystat 1500MDD). These measures are non-invasive and we have validated these for use in obese adolescents [42].
Liver function and plasma lipid profiles
Fasting blood samples (10 ml) will be taken by trained phlebotomists at M1 and M2. Liver function tests (including total protein, albumin, total bilirubin, liver function enzymes (ALP, GGT, ALT and AST) and lipid profiles (including cholesterol fractions and triglycerides) will be measured using an automated Clinical Chemistry Analyser.
Insulin resistance
Fasting glucose and insulin will be measured using an automated Clinical Chemistry Analyser. The homeostatic method will be used to calculate insulin resistance and beta cell function.
Adipokines and inflammatory markers
Adipose tissue is not only a site of energy storage, but also an active endocrine organ secreting a number of hormones and cytokines that play critical roles in body energy homeostasis and metabolism [43]. We will measure the following adipokines and cytokines at M1 and M2: leptin, resistin, adiponectin, interleukin-6, TNFα, CRP, plasminogen activator inhibitor 1 (PAI1) and soluble ICAM-1 in plasma using a multiplexed immunoassay, analysed on the Luminex 100IS.
Diet and activity
Participants will be asked to complete a 4 day food and activity records at M1 and M2. Food records will be analysed using a standard nutrient analysis package (FoodWorks). Physical activity habits will be assessed using the diary and the Adolescent Physical Activity Recall Questionnaire [40].
Allocation to groups
Treatment allocation will depend on gender and Tanner Stage (pubertal stage). Weighted randomisation will be used so that the participants will be allocated to the treatment group that minimises the gender/Tanner Stage imbalance between groups with a probability of 0.8 and will be conducted by the study statistician (RSW). Participants will be informed as to which group they have been assigned at their baseline assessment and if they are in the active diet groups, an immediate appointment with a study dietitian will be made. The control group will be given an appointment to attend in 12 weeks time when they will be offered the intervention treatment of their choice.
Compliance and retention strategies
Compliance to the dietary program will be monitored by the use of 4 day food dairies throughout the intervention and at each measurement point. To try and reduce attrition, volunteer families will have parking cost at the hospital paid and during the initial 12 week period there is frequent and intense therapist contact. In the feasibility study we documented a mean increase in plasma urea in the reduced carbohydrate group (not statistically significant) but it is suggestive that dietary protein shifts in the direction indicated by the food diaries. We will measure serum changes in urea and urates across groups over time and also measure serum vitamin B12 as a surrogate marker of protein intake as this has been shown to increase in adults on high protein diets [15]. We recognise this method has not been validated in children.
Sample size
Our sample size calculations were based on our primary comparison, the difference in change in BMI z-score between the low fat and reduced carbohydrate groups. In our feasibility study (n = 30), the mean (SD) of BMI z-score changes over 12 weeks were -0.20 (0.17) and -0.11 (0.08) for the low fat and reduced carbohydrate groups respectively. In order to observe a clinically important difference in change of BMI z-score between the two intervention groups of 0.09, with α = 0.05 and power of 80%, and assuming standard deviation of 0.12, we require 29 individuals in each intervention group to complete the study. Assuming that 20% of participants will drop out of the study (in our feasibility study our attrition rate was 17%), we will enrol 35 individuals in each of the diet intervention groups. If 12 participants enrolled to the control group complete the 12 week wait-list period, we will be able to detect a difference of change in BMI z-score of 0.13 between the control group and either of the diet intervention groups (α = 0.05, power = 80%). If we assume 20% of control-group participants will drop out of the study, we will need to enrol 15 individuals in the control group.
Statistical Analysis Plan
Primary analysis will use the intention to treat principle, assuming return to baseline values for non-completers. Differences between participants who completed and withdrew will be assessed using t tests for continuous variables and Fisher's Exact Test for categorical variables. We shall examine weight loss over time using a mixed-effects model with a random intercept and slope for each participant. This method controls for the non-independence in results from the same participant and allows for heterogeneity between participants. Potential co-variates (gender, Tanner Stage, baseline weight) will be assessed, and, if appropriate, incorporated into the model. We will examine the effects of losses of body weight and body fat on clinically important markers of disease risk (lipids, blood pressure, waist: hip ratio, insulin resistance) using analysis of covariance. Data generated from the psychometric questionnaires (self-concept, anxiety, self-esteem and quality of life) will be used as secondary outcome variables to examine the extent and nature of psychological distress in obese adolescents pre-treatment and mixed-effects models will be used to examine changes in these parameters and their relationship with weight and waist: hip ratio change. Statistical significance will be based on two-tailed tests, with p < 0.05 considered significant.